Dietlein M - Search Results

1

Metabolic Tumour Volume for Response Prediction in Advanced-Stage Hodgkin Lymphoma.

Mettler J, Müller H, Voltin CA, Baues C, Klaeser B, Moccia A, Borchmann P, Engert A, Kuhnert G, Drzezga AE, Dietlein M, Kobe C. Mettler J, et al. Among authors: dietlein m. J Nucl Med. 2018 Jun 7;60(2):207-11. doi: 10.2967/jnumed.118.210047. Online ahead of print. J Nucl Med. 2018. PMID: 29880508 Free PMC article.

2

[Hodgkin's lymphoma in nuclear medicine: diagnostic and therapeutic aspects].

Staak JO, Dietlein M, Engert A, Weihrauch MR, Schomäcker K, Fischer T, Eschner W, Borchmann P, Diehl V, Schicha H, Schnell R. Staak JO, et al. Among authors: dietlein m. Nuklearmedizin. 2003 Feb;42(1):19-24. Nuklearmedizin. 2003. PMID: 12601450 Review. German.

3

Imaging of central nervous system lymphomas with iodine-123 labeled rituximab.

Dietlein M, Pels H, Schulz H, Staak O, Borchmann P, Schomäcker K, Fischer T, Eschner W, Pogge von Strandmann E, Schicha H, Engert A, Schnell R. Dietlein M, et al. Eur J Haematol. 2005 Apr;74(4):348-52. doi: 10.1111/j.1600-0609.2004.00401.x. Eur J Haematol. 2005. PMID: 15777348

4

Treatment of refractory Hodgkin's lymphoma patients with an iodine-131-labeled murine anti-CD30 monoclonal antibody.

Schnell R, Dietlein M, Staak JO, Borchmann P, Schomaecker K, Fischer T, Eschner W, Hansen H, Morschhauser F, Schicha H, Diehl V, Raubitschek A, Engert A. Schnell R, et al. Among authors: dietlein m. J Clin Oncol. 2005 Jul 20;23(21):4669-78. doi: 10.1200/JCO.2005.09.098. J Clin Oncol. 2005. PMID: 16034043

5

[Radioimmunotherapy with yttrium-90 ibritumomab tiuxetan. Clinical considerations, radiopharmacy, radiation protection, perspectives].

Schomäcker K, Dietlein M, Schnell R, Pinkert J, Eschner W, Zimmermanns B, Fischer T, Engert A, Schicha H. Schomäcker K, et al. Among authors: dietlein m. Nuklearmedizin. 2005;44(4):166-77. doi: 10.1267/nukl05040166. Nuklearmedizin. 2005. PMID: 16163413 German.

6

[The incidentaloma of the thyroid. Over- or underuse of diagnostic procedure for an epidemiologic finding?].

Dietlein M, Kobe C, Schmidt M, Schicha H. Dietlein M, et al. Nuklearmedizin. 2005;44(5):213-24; quiz N41-2. Nuklearmedizin. 2005. PMID: 16395498 German.

7

[Therapy for non-toxic multinodular goiter: radioiodine therapy as attractive alternative to surgery].

Dietlein M, Dederichs B, Kobe C, Theissen P, Schmidt M, Schicha H. Dietlein M, et al. Nuklearmedizin. 2006;45(1):21-34; quiz N1-2. doi: 10.1267/nukl06010021. Nuklearmedizin. 2006. PMID: 16493511 Review. German.

8

Cell death induced by 131 I in a differentiated thyroid carcinoma cell line in vitro: necrosis or apoptosis?

Marx K, Moka D, Schomäcker K, Fischer T, Gabruk-Szostak B, Kobe C, Dietlein M, Schicha H. Marx K, et al. Among authors: dietlein m. Nucl Med Commun. 2006 Apr;27(4):353-8. doi: 10.1097/01.mnm.0000199475.08407.e2. Nucl Med Commun. 2006. PMID: 16531921

9

Yttrium-90 ibritumomab tiuxetan-induced complete remission in a patient with classical lymphocyte-rich Hodgkin's Lymphoma.

Schnell R, Dietlein M, Schomäcker K, Kobe C, Borchmann P, Schicha H, Hallek M, Engert A. Schnell R, et al. Among authors: dietlein m. Onkologie. 2008 Feb;31(1-2):49-51. doi: 10.1159/000111758. Epub 2008 Jan 22. Onkologie. 2008. PMID: 18268399

10

Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?

Kobe C, Eschner W, Sudbrock F, Weber I, Marx K, Dietlein M, Schicha H. Kobe C, et al. Among authors: dietlein m. Nuklearmedizin. 2008;47(1):13-7. Nuklearmedizin. 2008. PMID: 18278207

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

275 results

Search Page

Filters